Novoteris recently announced that the FDA has granted orphan drug designation for inhaled nitric oxide as a treatment for Cystic Fibrosis.
The pilot trial demonstrated an 8.8% absolute improvement from baseline after 2 weeks.
Phase 2 trials are planned for 2014.
More info here:
http://sixtyfiverosesblog.wordpress...-orphan-drug-status-for-nitric-oxide-therapy/
The pilot trial demonstrated an 8.8% absolute improvement from baseline after 2 weeks.
Phase 2 trials are planned for 2014.
More info here:
http://sixtyfiverosesblog.wordpress...-orphan-drug-status-for-nitric-oxide-therapy/